Experimental Diabetes Model in Chick Embryos Treated with Streptozotocin
-
- Yoshiyama Yuji
- Division of Clinical Pharmacy, Kyoritsu University of Pharmacy
-
- Sugiyama Takashi
- Division of Clinical Pharmacy, Kyoritsu University of Pharmacy
-
- Kanke Motoko
- Division of Clinical Pharmacy, Kyoritsu University of Pharmacy
Search this article
Abstract
The aim of the present study was to investigate whether diabetes model can be made by treatment of streptozotocin (STZ) in chick embryos and this model can be used to predict the effect of drug. When STZ (0.3 mg/egg) was injected into the albumen of fertile eggs on the 14th day of incubation, level of blood glucose significantly increased than that of the control on the 17th day of incubation, and level of serum insulin significantly decreased. In addition, the enhanced level of blood glucose in STZ-treated embryos reduced by injection of human insulin. In conclusion, STZ-treated embryos may be applicable to evaluate human insulin and anti-diabetes drugs as an experimental diabetes model.
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 28 (10), 1986-1988, 2005
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679603356032
-
- NII Article ID
- 110003666379
-
- NII Book ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 7453185
-
- PubMed
- 16204961
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed